NDC11 61958360101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 61958-3601-01 | 61958-3601 |
| 61958-3601-1 | 61958-3601 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BIXLENVO | BICTEGRAVIR/LENACAPAVIR | Gilead Sciences, Inc. | 072a3c7e-33fb-4a87-ba21-3d8dad3f5c48 | 2026-08-27 | Warnings, Adverse reactions | 61958-3601-1 61958-3601 61958360101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.